NO20092475L - Piperidinderivater anvendt for behandling av chemokin reseptor 5 medierte sykdommer - Google Patents

Piperidinderivater anvendt for behandling av chemokin reseptor 5 medierte sykdommer

Info

Publication number
NO20092475L
NO20092475L NO20092475A NO20092475A NO20092475L NO 20092475 L NO20092475 L NO 20092475L NO 20092475 A NO20092475 A NO 20092475A NO 20092475 A NO20092475 A NO 20092475A NO 20092475 L NO20092475 L NO 20092475L
Authority
NO
Norway
Prior art keywords
chemokine receptor
mediated diseases
derivatives used
piperidine derivatives
treat chemokine
Prior art date
Application number
NO20092475A
Other languages
English (en)
Norwegian (no)
Inventor
Alan Wellington Faull
Steven Swallow
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39048005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092475(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20092475L publication Critical patent/NO20092475L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20092475A 2006-12-11 2009-06-30 Piperidinderivater anvendt for behandling av chemokin reseptor 5 medierte sykdommer NO20092475L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86943606P 2006-12-11 2006-12-11
PCT/GB2007/004706 WO2008071927A1 (en) 2006-12-11 2007-12-10 Piperidine derivative used for treating chemokine receptor 5 mediated diseases

Publications (1)

Publication Number Publication Date
NO20092475L true NO20092475L (no) 2009-09-09

Family

ID=39048005

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092475A NO20092475L (no) 2006-12-11 2009-06-30 Piperidinderivater anvendt for behandling av chemokin reseptor 5 medierte sykdommer

Country Status (19)

Country Link
US (2) US20080139612A1 (es)
EP (1) EP2091946A1 (es)
JP (1) JP2010512376A (es)
KR (1) KR20090086588A (es)
CN (1) CN101558060A (es)
AR (1) AR064277A1 (es)
AU (1) AU2007331316A1 (es)
BR (1) BRPI0720291A2 (es)
CA (1) CA2671460A1 (es)
CL (1) CL2007003572A1 (es)
EC (1) ECSP099381A (es)
IL (1) IL198874A0 (es)
MX (1) MX2009005739A (es)
NO (1) NO20092475L (es)
PE (1) PE20081449A1 (es)
RU (1) RU2009119287A (es)
TW (1) TW200831483A (es)
UY (1) UY30770A1 (es)
WO (1) WO2008071927A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
US20100099708A1 (en) 2010-04-22
IL198874A0 (en) 2010-02-17
WO2008071927A1 (en) 2008-06-19
CN101558060A (zh) 2009-10-14
US20080139612A1 (en) 2008-06-12
ECSP099381A (es) 2009-07-31
AU2007331316A1 (en) 2008-06-19
PE20081449A1 (es) 2008-12-07
RU2009119287A (ru) 2011-01-20
AR064277A1 (es) 2009-03-25
MX2009005739A (es) 2009-06-08
UY30770A1 (es) 2008-07-31
TW200831483A (en) 2008-08-01
KR20090086588A (ko) 2009-08-13
EP2091946A1 (en) 2009-08-26
BRPI0720291A2 (pt) 2014-02-04
JP2010512376A (ja) 2010-04-22
CL2007003572A1 (es) 2008-08-22
CA2671460A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
WO2009055721A3 (en) 5-lipoxygenase activating protein (flap) inhibitor
NO20084744L (no) Trisubstituerte 1,2,4-triazoler
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20045677L (no) Inhibitorer av JAK- og CDK2-proteinkinaser
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
ATE557015T1 (de) 3,4-diarylpyrazole als proteinkinaseinhibitoren
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
DE60333387D1 (de) Triazolopyridazine als proteinkinase-inhibitoren
NO20055129L (no) Fenylsubstituerte karboksylsyrer
NO20092651L (no) Dihydropyridinderivater som er anvendelige som proteinkinaseinhibitorer
NO20071314L (no) Peptidiske vasopressinreseptoragonister
MX368157B (es) Formulaciones de sal de meglumina del acido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxilico.
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
JP2019510079A (ja) 血管収縮を特徴とする疾患を治療する方法
MX2011010732A (es) Pirimidinas sustituidas por imidazol utiles en el tratamiento de trastornos relacionados con glucogeno sintasa cinasa 3 como la enfermedad de alzheimer.
NO20091254L (no) Terapeutiske sammensetninger
BG108941A (en) Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
TW201206435A (en) Piperidinyl compound as a modulator of chemokine receptor activity
NO20070789L (no) Nikotinreseptoragonister for behandling av betennelsessykdommer
US7183285B2 (en) Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
TW200803839A (en) Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia
NO20071403L (no) 4- (fenylmetyl og substituerte fenylmetyl) - imidazol-2-tioner fungerende som spesifikke alfa2 adrenergen agonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application